Navigation Links
NuVasive to Present at Cowen and Company 29th Annual Healthcare Conference
Date:3/11/2009

rnal fixation products and its R&D pipeline emphasizes both MAS and motion preservation. NuVasive's Biologic product portfolio includes FormaGraft(R), Osteocel(R) Plus, and the Progentix(R) products, all of which are intended to facilitate fusion and complement the core fixation products.

NuVasive cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to: the uncertain process of seeking regulatory approval or clearance for NuVasive's products or devices, including risks that such process could be significantly delayed; the possibility that the FDA may require significant changes to NuVasive's products or clinical studies; the risk that products may not perform as intended and may therefore not achieve commercial success; the risk that competitors may develop superior products or may have a greater market position enabling more successful commercialization; the risk that additional clinical data may call into question the benefits of NuVasive's products to patients, hospitals and surgeons; and other risks and uncertainties more fully described in NuVasive's press releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.


'/>"/>
SOURCE NuVasive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NuVasive to Present at Barclays Capital Global Healthcare Conference
2. NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results
3. NuVasive Announces Web Cast and Conference Call of Fourth Quarter 2008 Results
4. NuVasive to Present at Canaccord Adams Musculoskeletal Conference
5. NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference
6. NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results
7. NuVasive to Present at 27th Annual J.P. Morgan Healthcare Conference
8. NuVasive to Present at 20th Annual Piper Jaffray Health Care Conference
9. NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
10. NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference
11. NuVasive Acquires First Stem Cell Bone Graft Substitute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Lexington, Kentucky (PRWEB) October 22, 2014 ... an agreement that will change the current location of ... Road to South Limestone across from the University of ... be a state-of-the-art ambulatory care center, owned and operated ... meet the orthopaedic needs of children and their families ...
(Date:10/22/2014)... Pass, OR (PRWEB) October 22, 2014 ... Southern California’s fresh water supply runs dangerously low, Southern ... change. Southern Oregon’s rivers, despite the lowest mountain snow ... even in late summer and early autumn.* That was ... authors of the new book “Hiking Southern Oregon,” during ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Although there are only ... time for many people who have trouble finding time within their ... to exercise for long periods of time to get in shape. ... goals while on the go. , Change Up Your Commute ... to work to add some exercise into your daily routine. If ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... be showing a genetic propensity for obesity as toddlers, a ... linked to increased body fat, but the same genes in ... researchers said. At 1 year, kids with these genes ... however, these genes were linked to excessive weight gain, the ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... 3.3 percent of children aged 2 to 19 are below ... number of underweight children aged 2 to 19 in the ... percent in 2003-2006, says a U.S. government study. , Being ... , Researchers at the U.S. Centers for Disease Control and ...
... , MEQUON, Wis., July 15 ... Maryland, has been recognized as the 2nd annual Wonderbox Technologies "Super ... Wonderbox Technologies staff during a special ceremony at the GDS offices ... Technologies performed an internal review of its clients, end users and ...
... BEIJING, July 15 New Enterprise Associates (NEA), ... four of its China-based portfolio companies were named to ... LianLian Pay, LineKong and Novast Pharmaceuticals. Spanning consumer technology, ... selected underscore the growth potential within several key areas ...
... on understanding of dilated cardiomyopathy , WEDNESDAY, July 15 ... disease and chronic heart failure in some children and ... , Dilated cardiomyopathy -- the most common cause of ... reason for a heart transplant -- is a condition ...
... memory of 10 minutes at this stage in development ... are only 30 weeks old may already possess short-term ... step into a better insight in the development of ... Jan G. Nijhuis, director of the Centre for Genetics, ...
... , , ... Inc., a leading provider of software and services for health and human ... management software company based in Killeen, Texas. Terms of the agreement were ... Crown provides Netsmart with a pharmacy management software solution, RxConnect, that will ...
Cached Medicine News:Health News:Wonderbox Technologies(R) Announces 2nd Annual Super User of the Year 2Health News:NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur 'Rising Stars' Honorees 2Health News:NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur 'Rising Stars' Honorees 3Health News:Gene Mutation Is Linked to Heart Muscle Disease 2Health News:Memory Forms at 30 Weeks in the Womb 2Health News:Memory Forms at 30 Weeks in the Womb 3Health News:Netsmart Technologies Acquires Pharmacy Management Software Company 2Health News:Netsmart Technologies Acquires Pharmacy Management Software Company 3
(Date:10/22/2014)... , Oct. 22, 2014  Cephasonics, a technology-innovation ... introduction of the cQUB™-1 (cQuest Ultrasound Box™-1), the first ... systems designed and manufactured by Cephasonics for purchase by ... model number. Cephasonics will be showcasing the cQUB-1 for ... this week in Chongqing, China ...
(Date:10/22/2014)...  Quest Diagnostics (NYSE: DGX ), the ... that its Board of Directors has elected Jeffrey M. ... 1, 2014. Including Dr. Leiden, the Board has 11 ... and CEO of Vertex Pharmaceuticals.   Dr. Leiden has ... in the pharmaceutical and biotechnology industries as well as ...
(Date:10/22/2014)... IRVINE, Calif. , Oct 22, 2014 ... Irvine, California , announced the receipt ... Small Business Innovation Research award (SBIR) from the National Institute of ... will fund the development of a Pan-HIV Protein Microarray ... the HIV-1 and HIV-2 subtypes and aid in the ...
Breaking Medicine Technology:Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2
... Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical ... on women,s healthcare and pain management, announced today ... The round was led by Longitude Capital ... Point Capital. Other current investors that participated in ...
... Center Association, JWCH Institute and the County of Los ... Community Health Downtown Los Angeles, a state-of-the-art medical facility ... homeless and low-income people in and around Skid Row. ... Street, is expected to meet the healthcare needs of ...
Cached Medicine Technology:Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio 2Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9,000 Patients Annually 2Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9,000 Patients Annually 3
... Microvolume technology , The ADVIA 1650 has ... as 2 L/test), reagent consumption (as low ... L/hour) - thus maximizing management efficiency. , ... cycle and system throughput of up to ...
... and controls interchangeable with other Roche/Hitachi ... training costs. Consistent patient results throughout ... handling. 70 positions for routine, STAT ... volumes. Intermix sample types. Intermix 5 ...
With the sample processing core unit and intelligent process management, combines a wide variety of analytical modules to enable full consolidation of clinical chemistry and immunochemistry....
... The Roche Diagnostics Task ... a state-of-the-art automation of ... the laboratories: decapping, sorting / ... aliquoting into bar code labeled ...
Medicine Products: